OXFORD DRUG DESIGN LIMITED
OXFORD CENTRE FOR INNOVATION, NEW ROAD, OXFORD  OX1 1BY- Active
- Private Limited Company
- Company No. 04305857
- Last Updated: 01 Mar 2024
Company Profile
OXFORD DRUG DESIGN LIMITED was incorporated on Wednesday, October 17, 2001 as a Private Limited Company with registered address in OXFORD. OXFORD DRUG DESIGN LIMITED has the status: Active and it's listed in the following category: Research and experimental development on biotechnology. This Private Limited Company has been operating for 23 years and 22 days.
Name | OXFORD DRUG DESIGN LIMITED |
---|---|
Company number | 04305857 |
Company type | Private Limited Company |
Incorporation date | 17 Oct 2001 |
Status | Active |
Industry (SIC 2007) |
Address
Registered Address |
OXFORD CENTRE FOR INNOVATION NEW ROAD OXFORD OX1 1BY |
---|---|
Country Of Origin | ENGLAND |
Map based on PostCode
Ownership Information
Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.
Name | Nature of Control |
---|---|
Mr Michael Underwood Nationality: British |
Dates: Wednesday, April 6, 2016 - Monday, May 20, 2019
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
|
Ip2ipo Limited Cornhill, EC3V 3ND |
Dates: Wednesday, April 6, 2016 - Monday, July 29, 2019
significant influence or control
|
Ip Venture Fund (Gp) Limited Cornhill, EC3V 3ND |
Dates: Wednesday, April 6, 2016 - Monday, July 29, 2019
significant influence or control
|
Accounts and Confirmation
Type of accounts | TOTAL EXEMPTION FULL |
---|---|
End of financial Year | 31 December |
Next annual accounts due | 30 September 2024, (-39 days left) |
Latest accounts | 31 December 2022 |
Next confirmation statement due | 26 November 2016 |
Last confirmation statement dated | 29 October 2015 |
Mortgages
No mortgages have been registered against OXFORD DRUG DESIGN LIMITED.
Previous Names
Name | Change Date |
---|---|
OXFORD DRUG DESIGN LIMITED | 17 Oct 2001 |
INHIBOX LIMITED | 15 May 2017 |